TrialThe American journal of tropical medicine and hygiene2020

Immunogenicity and Safety of a Tetravalent Recombinant Subunit Dengue Vaccine in Adults Previously Vaccinated with a Live Attenuated Tetravalent Dengue Vaccine: Results of a Phase-I Randomized Clinical Trial.

Anna P Durbin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.